August 15, 2018 (Washington, D.C.)
Scott Krygier Esq. recently joined Moarbes as Of Counsel of the Life Sciences Practice. Dr. Krygier’s expertise is counseling pharmaceutical, medical device, and biotechnology clients for over the past decade on issues related to compliance with the laws and regulations administered by FDA, USDA, and EPA.
Dr. Krygier and the head of the life sciences practice, Mr. Mason, have combined their collective 30 years of outside counsel legal expertise with practical knowledge gained by working in business to efficiently counsel clients on a comprehensive strategy for FDA and USPTO approval, along with downstream success in threatened or actual litigation. Given the FDA favors conventional extensions of existing treatments, whereas the USPTO and Federal Courts favor patents on the most unconventional and non-obvious such treatments, Dr. Krygier and Mr. Mason firmly believe a comprehensive strategy resolving that tension is critical to the long-term success of any life sciences company.
Dr. Krygier’s clients vary from the earliest to latest stages, i.e. from early product development and optimization to commercialization.